Pharma-Bio Serv PBSV Estimates

OTC PBSV
$0.54 +0.04 (+8.00%)
At close: Sep 4, 2026 · 4:00 PM EDT
Analyst Estimates

Pharma-Bio Serv, Inc. Revenue Estimates

Periods 18
Next Period Q3 26
Consensus 2.64 M

Analysts expect Pharma-Bio Serv, Inc. to report revenue of 2.64 M for Q3 26, against a range of 2.47 M to 2.81 M. The most recent reported quarter, Q2 26, came in at 2.70 M, a 2.0% beat against the 2.65 M consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28
Reported (Actual) 2.40 M2.40 M2.50 M2.40 M2.00 M2.10 M2.30 M2.70 M--------
High Estimate 3.68 M4.47 M3.01 M3.14 M3.34 M2.27 M3.03 M2.79 M2.81 M3.41 M3.01 M3.00 M3.18 M3.51 M3.02 M3.54 M
Low Estimate 3.16 M4.02 M2.65 M2.70 M2.83 M2.12 M2.53 M2.50 M2.47 M2.93 M2.52 M2.73 M2.83 M3.28 M2.57 M3.33 M
Consensus Estimate 3.42 M4.24 M2.83 M2.92 M3.09 M2.19 M2.78 M2.65 M2.64 M3.17 M2.77 M2.86 M3.00 M3.40 M2.80 M3.44 M
Analyst Estimates

Pharma-Bio Serv, Inc. Earnings Per Share (EPS) Estimates

Periods 18
Next Period Q3 26
Consensus 0.03

Analysts expect Pharma-Bio Serv, Inc. to report earnings per share of 0.03 for Q3 26, against a range of 0.03 to 0.03. The most recent reported quarter, Q2 26, came in at 0.01, a 66.7% miss against the 0.03 consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28
Reported (Actual) -0.010.000.000.00-0.010.010.000.01--------
High Estimate 0.030.030.020.030.030.010.020.030.030.030.020.020.040.040.030.03
Low Estimate 0.030.030.020.030.030.010.020.030.030.030.020.020.040.040.030.03
Consensus Estimate 0.030.030.020.030.030.010.020.030.030.030.020.020.040.040.030.03